{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:45:11Z","timestamp":1793126711422,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071955"],"award-info":[{"award-number":["82071955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02507-y","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T05:05:11Z","timestamp":1733720711000},"page":"905-918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Aggressive variants of papillary thyroid carcinoma: characteristics, influencing factors, and effectiveness of radioiodine therapy"],"prefix":"10.1007","volume":"48","author":[{"given":"Yuqi","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-467X","authenticated-orcid":false,"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"2507_CR1","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/erc-15-0555","volume":"23","author":"D Viola","year":"2016","unstructured":"Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L, Giani C, Sabini E, Passannati P, Puleo L, Matrone A, Pontillo-Contillo B, Battaglia V, Mazzeo S, Vitti P, Elisei R (2016) Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine-related Cancer 23:R185\u2013205. https:\/\/doi.org\/10.1530\/erc-15-0555","journal-title":"Endocrine-related Cancer"},{"key":"2507_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jso.21804","volume":"103","author":"OH Clark","year":"2011","unstructured":"Clark OH (2011) Thyroid cancer and lymph node metastases. J Surg Oncol 103:615\u2013618. https:\/\/doi.org\/10.1002\/jso.21804","journal-title":"J Surg Oncol"},{"key":"2507_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2505-7_1","volume":"2534","author":"AK Lam","year":"2022","unstructured":"Lam AK (2022) Papillary thyroid carcinoma: current position in Epidemiology, Genomics, and classification. Methods in molecular biology. (Clifton NJ) 2534:1\u201315. https:\/\/doi.org\/10.1007\/978-1-0716-2505-7_1","journal-title":"(Clifton NJ)"},{"key":"2507_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00265","author":"JX Mao","year":"2020","unstructured":"Mao JX, Zhang QH, Zhang HY, Zheng K, Wang R, Wang GZ (2020) Risk factors for Lymph Node Metastasis in Papillary thyroid carcinoma: a systematic review and Meta-analysis. Front Endocrinol 11. https:\/\/doi.org\/10.3389\/fendo.2020.00265","journal-title":"Front Endocrinol 11"},{"key":"2507_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-022-03146-0","volume":"78","author":"C Pizzimenti","year":"2022","unstructured":"Pizzimenti C, Fiorentino V, Ieni A, Martini M, Tuccari G, Lentini M, Fadda G (2022) Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine 78:1\u201312. https:\/\/doi.org\/10.1007\/s12020-022-03146-0","journal-title":"Endocrine"},{"key":"2507_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid 26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"2507_CR7","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","volume":"37","author":"A Coca-Pelaz","year":"2020","unstructured":"Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C, Nixon IJ, Randolph GW, M\u00e4kitie AA, Kowalski LP, Vander Poorten V, Sanabria A, Guntinas-Lichius O, Simo R, Zb\u00e4ren P, Angelos P, Khafif A, Rinaldo A, Ferlito A (2020) Papillary thyroid Cancer-aggressive variants and impact on management: a narrative review. Adv Therapy 37:3112\u20133128. https:\/\/doi.org\/10.1007\/s12325-020-01391-1","journal-title":"Adv Therapy"},{"key":"2507_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/his.13348","volume":"72","author":"ZW Baloch","year":"2018","unstructured":"Baloch ZW, LiVolsi VA (2018) Special types of thyroid carcinoma. Histopathology 72:40\u201352. https:\/\/doi.org\/10.1111\/his.13348","journal-title":"Histopathology"},{"key":"2507_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1507\/endocrj.EJ19-0414","volume":"67","author":"R Ohashi","year":"2020","unstructured":"Ohashi R (2020) Solid variant of papillary thyroid carcinoma: an under-recognized entity. Endocr J 67:241\u2013248. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0414","journal-title":"Endocr J"},{"key":"2507_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/cncy.22136","volume":"127","author":"ED Rossi","year":"2019","unstructured":"Rossi ED, Faquin WC, Pantanowitz L (2019) Cytologic features of aggressive variants of follicular-derived thyroid carcinoma. Cancer Cytopathol 127:432\u2013446. https:\/\/doi.org\/10.1002\/cncy.22136","journal-title":"Cancer Cytopathol"},{"key":"2507_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1094339","author":"J Xie","year":"2023","unstructured":"Xie J, Chen P, Wang J, Luo X, Luo J, Xiong X, Li C, Pan L, Wu J, Feng H, Ouyang W (2023) Incorporation size of lymph node metastasis focus and pre-ablation stimulated tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases. Front Endocrinol 14. https:\/\/doi.org\/10.3389\/fendo.2023.1094339","journal-title":"Front Endocrinol 14"},{"key":"2507_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1530\/ec-19-0045","volume":"8","author":"G Zhu","year":"2019","unstructured":"Zhu G, Deng Y, Pan L, Ouyang W, Feng H, Wu J, Chen P, Wang J, Chen Y, Luo J (2019) Clinical significance of the BRAFV600E mutation in PTC and its effect on radioiodine therapy. Endocr Connections 8:754\u2013763. https:\/\/doi.org\/10.1530\/ec-19-0045","journal-title":"Endocr Connections"},{"key":"2507_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1210\/jc.2016-2555","volume":"102","author":"V Marotta","year":"2017","unstructured":"Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A (2017) Germline polymorphisms of the VEGF pathway predict recurrence in Nonadvanced differentiated thyroid Cancer. J Clin Endocrinol Metab 102:661\u2013671. https:\/\/doi.org\/10.1210\/jc.2016-2555","journal-title":"J Clin Endocrinol Metab"},{"key":"2507_CR14","doi-asserted-by":"publisher","unstructured":"Zhang J, Cheng X, Shen L, Wang X, Wang L, Sun X, Qu S (2020) The Association between Lymph Node Stage and clinical prognosis in thyroid Cancer. Front Endocrinol (Lausanne) 1190. https:\/\/doi.org\/10.3389\/fendo.2020.00090","DOI":"10.3389\/fendo.2020.00090"},{"key":"2507_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2217\/fon.16.10","volume":"12","author":"LY Wang","year":"2016","unstructured":"Wang LY, Ganly I (2016) Nodal metastases in thyroid cancer: prognostic implications and management. Future Oncol (London England) 12:981\u2013994. https:\/\/doi.org\/10.2217\/fon.16.10","journal-title":"Future Oncol (London England)"},{"key":"2507_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s00268-013-2345-6","volume":"38","author":"J Lee","year":"2014","unstructured":"Lee J, Song Y, Soh EY (2014) Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence. World J Surg 38:858\u2013862. https:\/\/doi.org\/10.1007\/s00268-013-2345-6","journal-title":"World J Surg"},{"key":"2507_CR17","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/jco.2014.59.8391","volume":"33","author":"MA Adam","year":"2015","unstructured":"Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA (2015) Presence and Number of Lymph Node Metastases are Associated with compromised survival for patients younger Than Age 45 years with papillary thyroid Cancer. J Clin Oncology: Official J Am Soc Clin Oncol 33:2370\u20132375. https:\/\/doi.org\/10.1200\/jco.2014.59.8391","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"2507_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/s0748-7983(03)00005-2","volume":"29","author":"SM Chow","year":"2003","unstructured":"Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong IS, Lau WH (2003) Diffuse sclerosing variant of papillary thyroid carcinoma\u2013clinical features and outcome. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol 29:446\u2013449. https:\/\/doi.org\/10.1016\/s0748-7983(03)00005-2","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"key":"2507_CR19","doi-asserted-by":"publisher","unstructured":"Crayton H, Wu K, Leong D, Bhimani N, Gild M, Glover A (2023) Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis. Endocrine-related Cancer 30. https:\/\/doi.org\/10.1530\/erc-22-0348","DOI":"10.1530\/erc-22-0348"},{"key":"2507_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaoncol.2019.6851","volume":"6","author":"AS Ho","year":"2020","unstructured":"Ho AS, Luu M, Barrios L, Chen I, Melany M, Ali N, Patio C, Chen Y, Bose S, Fan X, Mallen-St Clair J, Braunstein GD, Sacks WL, Zumsteg ZS (2020) Incidence and mortality risk Spectrum Across aggressive variants of papillary thyroid carcinoma. JAMA Oncol 6:706\u2013713. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6851","journal-title":"JAMA Oncol"},{"key":"2507_CR21","first-page":"6262","volume":"11","author":"S Wang","year":"2019","unstructured":"Wang S, Xiong Y, Zhao Q, Song H, Yi P, Liu C (2019) Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis. Am J Translational Res 11:6262\u20136270","journal-title":"Am J Translational Res"},{"key":"2507_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","volume":"42","author":"Y Ito","year":"2018","unstructured":"Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A (2018) Overall survival of papillary thyroid carcinoma patients: a single-Institution Long-Term Follow-Up of 5897 patients. World J Surg 42:615\u2013622. https:\/\/doi.org\/10.1007\/s00268-018-4479-z","journal-title":"World J Surg"},{"key":"2507_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3109\/0284186x.2011.602109","volume":"50","author":"D Ahn","year":"2011","unstructured":"Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J (2011) Clinical relationship between Hashimoto\u2019s thyroiditis and papillary thyroid cancer. Acta Oncol (Stockholm Sweden) 50:1228\u20131234. https:\/\/doi.org\/10.3109\/0284186x.2011.602109","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"2507_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bjorl.2017.08.012","volume":"84","author":"B Uhliarova","year":"2018","unstructured":"Uhliarova B, Hajtman A (2018) Hashimoto\u2019s thyroiditis\u2013 an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol 84:729\u2013735. https:\/\/doi.org\/10.1016\/j.bjorl.2017.08.012","journal-title":"Braz J Otorhinolaryngol"},{"key":"2507_CR25","doi-asserted-by":"publisher","unstructured":"Hu X, Wang X, Liang Y, Chen X, Zhou S, Fei W, Yang Y, Que H (2022) Cancer Risk in Hashimoto\u2019s Thyroiditis: a systematic review and Meta-analysis. Front Endocrinol 13. https:\/\/doi.org\/10.3389\/fendo.2022.937871","DOI":"10.3389\/fendo.2022.937871"},{"key":"2507_CR26","doi-asserted-by":"publisher","unstructured":"Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y, Guo C, Ren C (2022) Hashimoto\u2019s Thyroiditis: a double-edged Sword in thyroid carcinoma. Front Endocrinol 13. https:\/\/doi.org\/10.3389\/fendo.2022.801925","DOI":"10.3389\/fendo.2022.801925"},{"key":"2507_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/erc-17-0085","volume":"24","author":"V Marotta","year":"2017","unstructured":"Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A (2017) Hashimoto\u2019s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer. Endocrine-related Cancer 24:485\u2013493. https:\/\/doi.org\/10.1530\/erc-17-0085","journal-title":"Endocrine-related Cancer"},{"key":"2507_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4149\/neo_2018_170428N317","volume":"65","author":"H Ma","year":"2018","unstructured":"Ma H, Li L, Li K, Wang T, Zhang Y, Zhang C, Xu Y, Wu X, Yu J, Wang H, Xiang B, Zhang R, Wang W (2018) Hashimoto\u2019s thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients. Neoplasma 65:436\u2013440. https:\/\/doi.org\/10.4149\/neo_2018_170428N317","journal-title":"Neoplasma"},{"key":"2507_CR29","doi-asserted-by":"publisher","first-page":"1054297","DOI":"10.1155\/2022\/1054297","volume":"2022","author":"TZ Mohamed","year":"2022","unstructured":"Mohamed TZ, Sultan AAEA, Tag El-Din M, Mostafa AAE, Nafea MA, Kalmoush A-E, Nassar MS, Abdalgaleel MA, Hegab AM, Ibrahim AH, Baheeg M (2022) Incidence and risk factors of thyroid malignancy in patients with toxic nodular goiter. Int J Surg Oncol 2022:1054297\u20131054297. https:\/\/doi.org\/10.1155\/2022\/1054297","journal-title":"Int J Surg Oncol"},{"key":"2507_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312992","author":"V Suteau","year":"2021","unstructured":"Suteau V, Munier M, Briet C, Rodien P (2021) Sex Bias in differentiated thyroid Cancer. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222312992","journal-title":"Int J Mol Sci 22"},{"key":"2507_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/thy.2021.0361","volume":"32","author":"L Shobab","year":"2022","unstructured":"Shobab L, Burman KD, Wartofsky L (2022) Sex differences in differentiated thyroid Cancer. Thyroid 32:224\u2013235. https:\/\/doi.org\/10.1089\/thy.2021.0361","journal-title":"Thyroid"},{"key":"2507_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jss.2021.11.004","volume":"271","author":"LF Remer","year":"2022","unstructured":"Remer LF, Lee CI, Picado O, Lew JI (2022) Sex differences in papillary thyroid Cancer. J Surg Res 271:163\u2013170. https:\/\/doi.org\/10.1016\/j.jss.2021.11.004","journal-title":"J Surg Res"},{"key":"2507_CR33","doi-asserted-by":"publisher","first-page":"882727","DOI":"10.3389\/fmed.2022.882727","volume":"9","author":"L Zurnadzhy","year":"2022","unstructured":"Zurnadzhy L, Bogdanova T, Rogounovitch TI, Ito M, Tronko M, Yamashita S, Mitsutake N, Bolgov M, Chernyshov S, Masiuk S, Saenko VA (2022) Clinicopathological implications of the BRAF (V600E) mutation in papillary thyroid carcinoma of Ukrainian patients exposed to the Chernobyl Radiation in Childhood: a study for 30 years after the Accident. Front Med 9:882727. https:\/\/doi.org\/10.3389\/fmed.2022.882727","journal-title":"Front Med"},{"key":"2507_CR34","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/sla.0000000000003580","volume":"271","author":"KN Patel","year":"2020","unstructured":"Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, Angelos P, Chen H, Doherty GM, Fahey TJ 3rd, Kebebew E, Livolsi VA, Perrier ND, Sipos JA, Sosa JA, Steward D, Tufano RP, McHenry CR, Carty SE (2020) The American Association of Endocrine Surgeons Guidelines for the definitive Surgical management of thyroid disease in adults. Ann Surg 271:e21. https:\/\/doi.org\/10.1097\/sla.0000000000003580","journal-title":"Ann Surg"},{"key":"2507_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jnci\/djx227","volume":"110","author":"Y Huang","year":"2018","unstructured":"Huang Y, Qu S, Zhu G, Wang F, Liu R, Shen X, Viola D, Elisei R, Puxeddu E, Fugazzola L, Colombo C, Jarzab B, Czarniecka A, Lam AK, Mian C, Vianello F, Yip L, Riesco-Eizaguirre G, Santisteban P, O\u2019Neill CJ, Sywak MS, Clifton-Bligh R, Bendlova B, S\u00fdkorov\u00e1 V, Xing M (2018) BRAF V600E mutation-assisted risk stratification of Solitary Intrathyroidal Papillary thyroid Cancer for Precision Treatment. J Natl Cancer Inst 110:362\u2013370. https:\/\/doi.org\/10.1093\/jnci\/djx227","journal-title":"J Natl Cancer Inst"},{"key":"2507_CR36","doi-asserted-by":"publisher","first-page":"R499","DOI":"10.1530\/erc-16-0372","volume":"23","author":"V Marotta","year":"2016","unstructured":"Marotta V, Sciammarella C, Colao A, Faggiano A (2016) Application of molecular biology of differentiated thyroid cancer for clinical prognostication. Endocrine-related Cancer 23:R499. https:\/\/doi.org\/10.1530\/erc-16-0372","journal-title":"Endocrine-related Cancer"},{"key":"2507_CR37","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1530\/ec-17-0010","volume":"6","author":"HG Vuong","year":"2017","unstructured":"Vuong HG, Duong UN, Altibi AM, Ngo HT, Pham TQ, Tran HM, Gandolfi G, Hassell L (2017) A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connections 6:R8. https:\/\/doi.org\/10.1530\/ec-17-0010","journal-title":"Endocr Connections"},{"key":"2507_CR38","doi-asserted-by":"publisher","first-page":"41752","DOI":"10.1038\/srep41752","volume":"7","author":"M Matsuse","year":"2017","unstructured":"Matsuse M, Yabuta T, Saenko V, Hirokawa M, Nishihara E, Suzuki K, Yamashita S, Miyauchi A, Mitsutake N (2017) TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors. Sci Rep 7:41752. https:\/\/doi.org\/10.1038\/srep41752","journal-title":"Sci Rep"},{"key":"2507_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1507\/endocrj.k09e-025","volume":"56","author":"Y Ito","year":"2009","unstructured":"Ito Y, Fukushima M, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 56:759\u2013766. https:\/\/doi.org\/10.1507\/endocrj.k09e-025","journal-title":"Endocr J"},{"key":"2507_CR40","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/cmar.S292395","volume":"13","author":"C Yun","year":"2021","unstructured":"Yun C, Wu M, Xiao J, Liu Y, Zhang W, Cao J (2021) Analysis of curative effect and influencing factors of N1 stage papillary thyroid Micro-carcinoma and Papillary thyroid Non-micro Carcinoma after initial Radioactive iodine ablation therapy. Cancer Manage Res 13:1427\u20131434. https:\/\/doi.org\/10.2147\/cmar.S292395","journal-title":"Cancer Manage Res"},{"key":"2507_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cen.12282","volume":"80","author":"C Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez C, Aulinas A, Colom C, Tundidor D, Mendoza L, Corcoy R, Mato E, Alc\u00e1ntara V, Urgell Rull E, de Leiva A (2014) Thyroglobulin as early prognostic marker to predict remission at 18\u201324 months in differentiated thyroid carcinoma. Clin Endocrinol 80:301\u2013306. https:\/\/doi.org\/10.1111\/cen.12282","journal-title":"Clin Endocrinol"},{"key":"2507_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s13139-013-0220-x","volume":"47","author":"H Kim","year":"2013","unstructured":"Kim H, Kim SJ, Kim IJ, Kim K, Kim S, Kim BH, Kim SS, Kyung JY (2013) Limited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancer. Nuclear Med Mol Imaging 47:268\u2013272. https:\/\/doi.org\/10.1007\/s13139-013-0220-x","journal-title":"Nuclear Med Mol Imaging"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02507-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T08:48:18Z","timestamp":1743324498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02507-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02507-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the Ethics Committee of Zhujiang Hospital of SMU (batch no. 2024-KY-002-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}